Dcc Plc · LSE:DCC
Dcc — Merger or Acquisition (September 2022)
12 slides from Dcc's merger presentation, Sep 8, 2022
Slide 1: Acquisition of Medi-Globe
Acquisition of Medi-Globe 8 September 2022
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any shares or other securities of DCC plc (“DCC”). This presentation contains some forward-looking statements that represent DCC’s expectations for its business, based on cu
Slide 3: Our Strategy
Our Strategy To continue to build a growing, sustainable and cash generative business which consistently provides returns on capital employed well in excess of its cost of capital. Our strategic enablers are key disciplines that enable use to deliver against our priorities Marketing Operational exce
Slide 4: Our priorities for capital deployment
Our priorities for capital deployment Our capital deployment priorities will deliver substantial growth and are aligned to the growth trends in our chosen sectors Our capital deployment priorities Organic development Acquisitions at ROCE Scaling our DCC Health & Beauty and investment well ahead of W
Slide 5: Largest Healthcare acquisition to date
Largest Healthcare acquisition to date Creates scale platform in European medical devices sector 01 02 03 Medi-Globe is focused on single-use Further material expansion of DCC Vital’s Acquisition based on medical devices used in minimally presence in the European healthcare an enterprise value of ap
Slide 6: Overview of Medi-Globe
Overview of Medi-Globe Leading global player in single use medical devices for endoscopy in gastroenterology and urology • Medi-Globe is a leading international medical devices business Revenue by geography developing, manufacturing and distributing single use medical devices Germany • Founded in 19
Slide 7: Focused on growing therapeutic areas
Focused on growing therapeutic areas Medi-Globe therapeutic areas Medi-Globe devices • Medi-Globe is a leading global player in its focus areas of • Endoscopy is a minimally invasive procedure which involves gastroenterology and urology – market sectors valued at €3bn today examining the inside of t
Slide 8: DCC Vital's medical devices strategy
DCC Vital’s medical devices strategy Medi-Globe accelerates DCC Vital's vision to build an international own-brand medical device business focussed on mid-tech single use medical devices for minimally invasive surgeries and related procedures Direct infrastructure in UK & Irl Direct infrastructure G
Slide 9: Attractive financial profile
Attractive financial profile 01 02 03 Provides DCC Vital with a European Revenues of c.€120m (£103m) at Acquisition at an Enterprise Value of platform of scale in medical devices to attractive operating margins c.€245m (£213m) complement its existing platform in the primary care sector 04 05 06 Clea
Slide 10: Appendix
Appendix
Slide 11: DCC Healthcare
DCC Healthcare FY2022 DCC Vital DCC Health & Beauty Solutions Revenue £765.2m Sales, marketing and distribution of Specialist service provider - NPD, Operating profit £100.4m medical products to healthcare formulation, manufacturing and providers in UK, Ireland, DACH & packaging – to international h
Slide 12: DCC Vital evolution
DCC Vital evolution Pro Forma Revenue c.£500m Platform acquisition in Strategy significantly sharpened over recent years – now focused on European Medical building substantial European positions in: Devices • Own-brand medical devices; • Primary Care supplies and services; while maintaining our stro